BioSpace News Archive

An interim analysis of the Phase III P302 study showed Moderna’s investigational flu shot, mRNA-1010, fell short of the statistical threshold for early success.

A California judge denied Elizabeth Holmes’ motion for release pending appeal, ruling that the former Theranos CEO must serve her prison sentence while she appeals her guilty verdict.

Junshi Biosciences announced Tuesday that its ovarian cancer candidate, senaparib, met the primary endpoint in a Phase III interim analysis.

Following mixed Phase I/II data for its homocystinuria hopeful pegtarviliase, Aeglea lays off all but 10 employees and launches a sweeping strategic review.

A look at the differences among types of retirement accounts, and how to evaluate which is best for you

Alpenglow Biosciences today announced a collaboration with Mayo Clinic to integrate Alpenglow’s 3D spatial biology platform to accelerate drug development and advance clinical diagnostics.

IntraBio Inc announced it completed and closed its $15 Million Series C funding round on April 5, 2023.

BioSkryb Genomics, a pioneer in comprehensive single-cell multiomic research solutions, today announced that it will share new, groundbreaking research related to single-cell analysis of breast cancer biopsies and the expansion of its ResolveDNA® product line at the AACR 2023 Annual Meeting in Orlando, Florida.

Outset Medical, Inc. is presenting five new abstracts providing promising insights on the clinical and financial benefits of home hemodialysis, gender biases toward female nephrologists and other pertinent topics related to kidney disease.

Altamira Therapeutics (“Altamira” or the “Company”) (Nasdaq:CYTO) today announced the publication of the detailed results from its TRAVERS Phase 2 trial with AM-125 (intranasal betahistine) in surgery-induced acute vestibular syndrome (AVS).